PALB2 mutations and prostate cancer risk and survival.

Dominika WokołorczykWojciech KluźniakKlaudia StempaBogna RusakTomasz HuzarskiJacek GronwaldKatarzyna GliniewiczAniruddh KashyapSylwia MorawskaTadeusz DębniakAnna JakubowskaMarek SzwiecPaweł DomagałaJan LubińskiSteven A NarodMohammad R AkbariCezary Cybulskinull null

Published in: British journal of cancer (2021)

In Poland, PALB2 mutations predispose to an aggressive and lethal form of prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
benign prostatic hyperplasia
free survival